Bandyopadhyay Abhishek, Williamson Lauren E, Sirohi Devika, Bailey Kevin, Gilliland Theron, Klose Thomas, Buda Geeta, Trivette Andrew, Sun Chengqun, Julander Justin G, Klimstra William B, Crowe James E, Kuhn Richard J
Department of Biological Sciences, Purdue University, West Lafayette, IN, 47907, USA.
The Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Nat Commun. 2025 Aug 19;16(1):7716. doi: 10.1038/s41467-025-60505-x.
Eastern equine encephalitis virus (EEEV) is a mosquito-transmitted alphavirus that can cause severe encephalitis in humans and horses with a high case fatality rate. There are no licensed EEEV vaccines or therapeutics for human use, warranting the need to better understand the human immune response against EEEV. Here we present a cryo-EM reconstruction of the chimeric virus, Sindbis (SINV)/EEEV, in complex with a potently neutralizing and efficacious intact human IgG1 antibody in a mouse model of infection and disease. This antibody requires bivalency to recognize a quaternary epitope on the E2 glycoprotein and cross-links two virus spikes across the icosahedral two-fold axis through a unique binding mode. Kinetic analysis of the binding interaction provides insights into this distinguishing feature. Mechanistically, the antibody inhibits viral entry into cells through blockade of receptor binding and early fusion events but does not block egress, thereby, exclusively targeting an epitope found on intact virions. The discovery of the quaternary epitope and unique binding mode recognized by this antibody together advance our understanding of the complexity of antibody-antigen interactions and can aid in vaccine design to elicit recognition of distinct epitopes of clinically relevant alphaviruses.
东部马脑炎病毒(EEEV)是一种由蚊子传播的甲病毒,可在人类和马匹中引起严重脑炎,病死率很高。目前尚无用于人类的许可的EEEV疫苗或治疗方法,因此有必要更好地了解人类针对EEEV的免疫反应。在此,我们展示了嵌合病毒辛德比斯病毒(SINV)/EEEV与一种强效中和且有效的完整人IgG1抗体在感染和疾病小鼠模型中的复合物的冷冻电镜重建。该抗体需要双价才能识别E2糖蛋白上的四级表位,并通过独特的结合模式在二十面体二重轴上交联两个病毒刺突。结合相互作用的动力学分析为这一独特特征提供了见解。从机制上讲,该抗体通过阻断受体结合和早期融合事件来抑制病毒进入细胞,但不阻断病毒释放,因此专门靶向完整病毒粒子上发现的一个表位。该抗体识别的四级表位和独特结合模式的发现共同推进了我们对抗体-抗原相互作用复杂性的理解,并有助于疫苗设计,以引发对临床相关甲病毒不同表位的识别。